Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

Actelion HQ Switzerland

Actelion complete Ceptaris purchase

Follows approval of lymphoma gel product Valchlor

- PMLiVE

Double asthma approval in Japan lifts SkyePharma

Regulatory wins for company’s commercial partners GSK and Kyorin

- PMLiVE

Boehringer to work with Roche on cancer diagnostics

Will collaborate with Roche subsidiary Ventana Medical Systems

- PMLiVE

Owen Mumford appoints general manager for SEMEA

Eric Del Cotto to oversee operations of medical device firm in Southern Europe, Middle East and Africa

Merrill Brink pharmacovigilance

Pharmacovigilance and adverse event reporting: Five keys for establishing worldwide best practice

Pharmacovigilance, an arm of patient care with a charter to make the best use of medicines and data for the treatment or prevention of disease, is taking on growing importance...

Merrill Brink International

Ensuring you are EU Medical Device e-labelling compliant - A best practice strategy

Ensuring you are EU Medical Device e-labelling compliant – A best practice strategy

The EU Directive No 207/2012 on electronic labelling for Instructions for Use (IFUs) for certain medical devices was adopted effective March 9, 2012.

Merrill Brink International

Google taps ex-Genentech CEO to lead its new health company

Says Calico will have particular focus on diseases associated with ageing

- PMLiVE

Hikma pushes further into Africa with Ethiopian JV

Forms alliance with MIDROC to create HikmaCure

- PMLiVE

US NIH provides $45m for Alzheimer’s research

Projects will investigate basic science of the neurological condition

- PMLiVE

GSK hands back rights to ChemoCentryx drug

Investigational IBD treatment vercirnon disappoints in phase III

- PMLiVE

CDM Group re-brands non-US businesses

Develops platform for agencies to focus on growth

- PMLiVE

Online doctor collaboration demonstrates value

Developer says web and mobile app iConsult has helped diagnose thousands of cases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links